Skip to main content

Table 2 (abstract A35). Analysis of OraQuick ADVANCE saliva cross-reactivity with blood tests

From: Abstracts from the 4th Annual Student Medical Summit

HIV-1 Diagnostic Test Participants Testing Reactive
n (%) 		p value vs OraQuick ADVANCE
OraQuick ADVANCE 0 of 120 (0%) ----
BioRad GS 65 of 120 (54%) < 0.0001
Abbott Architect 76 of 120 (63%) < 0.0001
Alere Determine 58 of 120 (48%) < 0.0001
Abbott Prism1 41 of 43 (95%) < 0.0001
  1. 1 Abbott Prism was only used if samples tested negative on all three of the fourth-generation antigen/antibody tests (n=41)
Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us